← All companies

IPHA

Innate Pharma S.A.

IPHA Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$1.72

-0.03 -1.43%

Key statistics

from XBRL data in SEC filings

Market cap

$161M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$1.17 – $2.62

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 23, 2026 6-K Jul 21, 2026 6-K May 22, 2026 6-K May 19, 2026 6-K May 13, 2026 6-K May 12, 2026 6-K May 6, 2026 6-K Apr 23, 2026 6-K Apr 17, 2026 6-K Apr 13, 2026 6-K Apr 13, 2026 6-K Apr 8, 2026 6-K Apr 3, 2026 6-K Apr 2, 2026 20-F Apr 1, 2026 6-K Mar 26, 2026 6-K Mar 19, 2026 6-K Feb 18, 2026 6-K Jan 7, 2026 6-K Dec 22, 2025 6-K Dec 11, 2025 6-K Nov 28, 2025 6-K Nov 17, 2025 6-K Nov 13, 2025 6-K Nov 10, 2025 6-K Nov 5, 2025 6-K Oct 15, 2025 6-K Sep 17, 2025 6-K Sep 17, 2025 6-K Sep 15, 2025 6-K Sep 10, 2025 6-K Sep 2, 2025 6-K Aug 4, 2025 6-K Jul 29, 2025 6-K Jul 7, 2025 6-K Jun 17, 2025 6-K Jun 13, 2025 6-K May 27, 2025 6-K May 23, 2025 6-K May 23, 2025